Drug · DIN 02494426
XEMBIFY
ALSO KNOW AS IMMUNE GLOBULIN (HUMAN)
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since December 10, 2019.
- Drug Identification Number (DIN)
- 02494426
- Company (DIN owner)
- Grifols Therapeutics LlcClayton, North Carolina, United States
- Schedule
- Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Immunoglobulins, normal human, for extravasc. adm J06BA01
- Class
- Human
- Record last updated
- August 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| IMMUNOGLOBULIN (HUMAN) | 20 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 10, 2019: NOC 22997New Drug Submission (NDS)